Just Published: "Global Lung Cancer Liquid Biopsy Market 2017-2021"

03.03.2018 21:13:05 - New Healthcare market report from TechNavio: "Global Lung Cancer Liquid Biopsy Market 2017-2021"

( - A liquid biopsy helps to identify free-floating tumor DNA (also known as circulating DNA) within the blood sample of a patient. Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. It is observed that the use of a liquid biopsy to identify carcinogenic cells of


lungs will help in the early diagnosis of lung cancer.

Full Report Details at
- ..

Technavio's analysts forecast the global lung cancer liquid biopsy market to grow at a CAGR of 17.15% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global lung cancer liquid biopsy market for 2017-2021. To calculate the market size, the report considers the sales and values of lung cancer liquid biopsy assays.
The market is divided into the following segments based on geography:

* Americas

Technavio's report, Global Lung Cancer Liquid Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* Biocept
* Exosome Diagnostics
* F. Hoffmann-La Roche

Other prominent vendors

* AccuraGen
* Agena Bioscience
* Biodesix
* Bio-Rad Laboratories
* Cancer Genetics
* CellMax Life
* Circulogene
* Cynvenio Biosystems
* EntroGen
* Epic Sciences
* Epigenomics
* Fluxion Biosciences
* Freenome
* Gencurix
* Genetracer Biotech
* Genomic Health
* Grail
* Guardant Health
* HeliTec
* Inivata
* Lonza
* MedGenome
* Nanoview Diagnostics
* Natera
* Novogene
* OncoCyte
* OncoDNA
* Pathway Genomics
* Personal Genome Diagnostics
* Predicine
* Shuwen Biotech
* Sysmex
* Thermo Fisher Scientific
* Transgenomic
* Trovagene

Market driver

* Rising incidence of lung cancer
* For a full, detailed list, view our report

Market challenge

* High cost of lab testing procedure
* For a full, detailed list, view our report

Market trend

* Vendors' focus on clinical trials
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2021 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Biocept, Exosome Diagnostics, F. Hoffmann-La Roche, QIAGEN, AccuraGen, Agena Bioscience, BARD1, BGI, Biodesix, Bio-Rad Laboratories, Cancer Genetics, CellMax Life, Circulogene, CLEARBRIDGE BIOMEDICS, Cynvenio Biosystems, EntroGen, Epic Sciences, Epigenomics, Fluxion Biosciences, Freenome, Gencurix, Genetracer Biotech, Genomic Health, Grail, Guardant Health, HeliTec, Inivata, Lonza, MedGenome, Nanoview Diagnostics, Natera, Novogene, OncoCyte, OncoDNA, Pathway Genomics, Personal Genome Diagnostics, Predicine, Shuwen Biotech, Sysmex, Thermo Fisher Scientific, Transgenomic, Trovagene

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

Bill Thompson
Phone: 1.413.485.7001


Disclaimer: If you have any questions regarding information in this article please contact the author. Please do not contact We are not able to assist you. disclaims content contained in this article. is not authorized to give any information about content and not responsible for content posted by third party.
refer this article
Print This Article
Terms Of Use Privacy About Contact Us